AU2001236001A1 - Immune enhancement compositions and use thereof - Google Patents

Immune enhancement compositions and use thereof

Info

Publication number
AU2001236001A1
AU2001236001A1 AU2001236001A AU3600101A AU2001236001A1 AU 2001236001 A1 AU2001236001 A1 AU 2001236001A1 AU 2001236001 A AU2001236001 A AU 2001236001A AU 3600101 A AU3600101 A AU 3600101A AU 2001236001 A1 AU2001236001 A1 AU 2001236001A1
Authority
AU
Australia
Prior art keywords
immune enhancement
enhancement compositions
compositions
immune
enhancement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236001A
Inventor
Shinobu Ito
Eiji Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Publication of AU2001236001A1 publication Critical patent/AU2001236001A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001236001A 2000-02-29 2001-02-28 Immune enhancement compositions and use thereof Abandoned AU2001236001A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000055019 2000-02-29
JP2000-55019 2000-02-29
US25374400P 2000-11-29 2000-11-29
US60253744 2000-11-29
PCT/JP2001/001512 WO2001064245A1 (en) 2000-02-29 2001-02-28 Immune enhancement compositions and use thereof

Publications (1)

Publication Number Publication Date
AU2001236001A1 true AU2001236001A1 (en) 2001-09-12

Family

ID=26586479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236001A Abandoned AU2001236001A1 (en) 2000-02-29 2001-02-28 Immune enhancement compositions and use thereof

Country Status (4)

Country Link
EP (1) EP1264600A4 (en)
AU (1) AU2001236001A1 (en)
CA (1) CA2401352A1 (en)
WO (1) WO2001064245A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4111856B2 (en) 2002-04-12 2008-07-02 昭和電工株式会社 Stabilized ascorbic acid derivatives
JP2006143661A (en) * 2004-11-19 2006-06-08 Nippon Menaade Keshohin Kk Nf kappa b inhibitor
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02209807A (en) * 1989-02-09 1990-08-21 Takeda Chem Ind Ltd Anti-inflammatory agent
US5114957A (en) * 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
WO1995028925A1 (en) * 1994-04-27 1995-11-02 Seiichi Tanuma Disease preventive/remedy
JPH10155429A (en) * 1996-11-27 1998-06-16 Showa Denko Kk Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition
EP0875246A1 (en) * 1997-04-04 1998-11-04 Showa Denko Kabushiki Kaisha Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer
JPH10298174A (en) * 1997-04-30 1998-11-10 Showa Denko Kk Ascorbic acid derivative and vitamin c agent containing the same
JP3772468B2 (en) * 1997-06-11 2006-05-10 昭和電工株式会社 L-ascorbic acid-2-phosphate zinc salt and method for producing the same

Also Published As

Publication number Publication date
EP1264600A4 (en) 2004-11-17
CA2401352A1 (en) 2001-09-07
WO2001064245A1 (en) 2001-09-07
EP1264600A1 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2002211717A1 (en) Stresscopins and their uses
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001276461A1 (en) Cleaning compositions and their use
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU2001240018A1 (en) Adeno-associated viral compositions and methods
AU2001229439A1 (en) Bioconjugates and uses thereof
AU1152601A (en) Compositions and their use
GB0027391D0 (en) Films and compositions
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
GB9922135D0 (en) Compositions and uses
AU8975701A (en) Novel composition and use
AU2001236001A1 (en) Immune enhancement compositions and use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001239954A1 (en) Cleaning compositions and use thereof
AU2000251520A1 (en) Antiviral methods and compositions
AU2002359869A1 (en) Pak5-related compositions and methods
AU5104101A (en) Composition and use
AUPQ723300A0 (en) Compositions and uses therefor - III